Advanced and Metastatic Silent Neuro-Endocrine Tumors

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced and Metastatic Silent Neuro-Endocrine Tumors trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT00688623

RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe

To evaluate the preliminary efficacy and safety of RAD001 as monotherapy for first-line treatment of patients with metastatic papillary carcinoma of the kidney.

France, Germany73 participantsStarted 2009-06-24

Treatment: Everolimus